MEI Pharma Inc
For the period ended Jun 30, 2024. Filed Sep 19, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Sep 19, 2024
LITS$0.95-6.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
None of ourofficers or directors have adopted, modified or terminated trading plans under a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement for the year ended June 30, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.